Are you interested in Preference studies? You have heard about DCE, but not sure whether this approach is the most appropriate for you? You want to know how to define such a project and understand outcomes you would expect from?

On June 25th, 2021 our DCE webinar took place.

A Preference study is a must have for any patient-centric organization when decisions have to be made to drive a product development and ensure it meets patients’ expectations.

Among the different approaches possible, the Discrete Choice Experiment is now recognized as a gold standard and yet, few projects using this methodology have been shared.

This webinar, organized by Xtalks, showed:

  • The definition of DCE
  • What is the value of DCE
  • Best practices implementation How to build a preference study using DCE

Access the replay

About the speakers

This live session was hosted by Lise Radoszycki Chief Operating Officer at Carenity and Nawal Bent-Ennakhil Lead Epidemiologist at Takeda.


Lise is Carenity’s Chief Operating Officer – Now part of the EvidentIQ Group. She oversees and coordinates the actions of the Data Science team which produces real-life studies, along with all digital projects and strategy to grow and engage the platform’s communities. She co-chairs Carenity’s Science and Ethics Committee.

Lise Radoszycki is a Method and Models statistic engineer with a degree from INSA (National Institute of Applied Sciences) in Toulouse, France. She also studied at the Universidad de Guadalajara (Mexico). She’s an active member of AFCRO (French CRO Association) and participates in the European think-tank Health Data Institute.


Nawal is Lead Epidemiologist at Takeda. Nawal is an epidemiologist by training. She has been leading Real World Evidence projects for more than 10 years now. She held several positions within HEOR and RWE teams and she is now lead Epidemiologist at Takeda EUCAN. Nawal has been closely managing the DCE-Preference Study Project with Carenity.

She will share her experience of collaborating with Carenity on such a project. She will explain why the DCE methodology has been chosen, what were the challenges of such methodology, how Carenity’s Team support Takeda EUCAN with the methodology its deployment and analysis of the results, what have been the main learnings of this methodology and how results will be used by Takeda EUCAN.